ACTRN12608000398303终止4 期
Efficacy of low dose escitalopram v's placebo in the amelioration of anxiety and fatigue in patients who are unwell or suffer chronic illness
Mood Research Foundation (WA)0 个研究点目标入组 50 人开始时间: 2008年8月8日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 终止
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 85 Years（—）
- 性别
- All
入选标准
- •Chronic illness - patients who are generally unwell for an extended period.
排除标准
- •Patients with Malignancy or taking any prescribed antidepressant and/or pyschotrophic medication will be excluded from the trial.
研究者
相似试验
招募中
3 期
Effect of of escitalopram and relaxation on hot flashes of patients with breast cancerIRCT2017072834482N2Vice chancellor for Research, Kermanshah University of Medical Sciences87
已完成
2 期
Evaluation of the effect of Escitalopram versus placebo trial on changing the neuroticismeuroticism or neuroticism.Post-traumatic stress disorder, acuteF43.11IRCT20211208053331N1Ahvaz University of Medical Sciences172
招募中
3 期
Treatment of depressive symptoms in patients with heart failureDepression.Major depressive disorder, single episode, mildF32.0IRCT20190525043700N5Babol University of Medical Sciences80
已完成
3 期
Escitalopram ?s effectiveness on treatment of depressive disorder and improvement of quality of life in patients who are undergone coronary artery bypass graft surgeryIRCT20140126016374N2niversity of social welfare and rehabilitation sciences50
进行中（未招募）
1 期
A Randomised Controlled Trial of Escitalopram and Nortriptyline compared with placebo, and standard psychological care, for depression in Parkinson’s diseaseDepression in Parkinson's diseaseMedDRA version: 20.0Level: PTClassification code 10012378Term: DepressionSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2018-002942-35-GBniversity College London Comprehensive Clinical Trials Unit408